{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:23:32Z","timestamp":1787163812239,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03181-4","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:13:49Z","timestamp":1757913229000},"page":"411-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment failure in patients with obesity with venous thromboembolism receiving truncated vs. recommended lead-in times with apixaban at an academic medical center"],"prefix":"10.1007","volume":"59","author":[{"given":"Allison","family":"Murchison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rockhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bredhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"issue":"8","key":"3181_CR1","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3390\/jcm9082467","volume":"9","author":"M Nicholson","year":"2020","unstructured":"Nicholson M, Chan N, Bhagirath V, Ginsberg J (2020) Prevention of venous thromboembolism in 2020 and beyond. J Clin Med 9(8):2467. https:\/\/doi.org\/10.3390\/jcm9082467. Published 2020 Aug 1","journal-title":"J Clin Med"},{"issue":"19","key":"3181_CR2","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel TL, Neumann I, Ageno W et al (2020) American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4(19):4693\u20134738. https:\/\/doi.org\/10.1182\/bloodadvances.2020001830","journal-title":"Blood Adv"},{"key":"3181_CR3","doi-asserted-by":"publisher","unstructured":"Stevens SM, Woller SC, Kreuziger LB et al (2022) Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report [published correction appears in Chest. ;162(1):269. doi: 10.1016\/j.chest.2022.05.028]. Chest. 2021;160(6): e545-e608. https:\/\/doi.org\/10.1016\/j.chest.2021.07.055","DOI":"10.1016\/j.chest.2021.07.055"},{"issue":"13","key":"3181_CR4","doi-asserted-by":"publisher","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker E, Warden A (2020) Direct oral anticoagulant use: A practical guide to common clinical challenges. J Am Heart Assoc 9(13):e017559. https:\/\/doi.org\/10.1161\/JAHA.120.017559","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"3181_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1302507","volume":"369","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A et al (2013) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369(9):799\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1302507","journal-title":"N Engl J Med"},{"issue":"26","key":"3181_CR6","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","volume":"363","author":"EINSTEIN Investigators","year":"2010","unstructured":"Investigators EINSTEIN, Bauersachs R, Berkowitz SD et al (2010) Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363(26):2499\u20132510. https:\/\/doi.org\/10.1056\/NEJMoa1007903","journal-title":"N Engl J Med"},{"issue":"1","key":"3181_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11239-015-1315-2","volume":"41","author":"MA Smythe","year":"2016","unstructured":"Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK (2016) Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis 41(1):165\u2013186. https:\/\/doi.org\/10.1007\/s11239-015-1315-2","journal-title":"J Thromb Thrombolysis"},{"key":"3181_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/IJGM.S392505","volume":"16","author":"GB Korayem","year":"2023","unstructured":"Korayem GB, Alshaya OA, Alnajjar N et al (2023) Real-world evaluation of the safety and effectiveness of Apixaban & Rivaroxaban lead-in dosing compared to parenteral lead-in dosing in the treatment of venous thromboembolism: a multi-center retrospective cohort study. Int J Gen Med 16:129\u2013140. https:\/\/doi.org\/10.2147\/IJGM.S392505","journal-title":"Int J Gen Med"},{"issue":"1","key":"3181_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010199","volume":"12","author":"OA Alshaya","year":"2022","unstructured":"Alshaya OA, Korayem GB, Al Yami MS et al (2022) Comparative effectiveness of Apixaban and Rivaroxaban lead-in dosing in VTE treatment: observational multicenter real-world study. J Clin Med 12(1):199. https:\/\/doi.org\/10.3390\/jcm12010199","journal-title":"J Clin Med"},{"issue":"2","key":"3181_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11239-022-02641-5","volume":"54","author":"M Williams","year":"2022","unstructured":"Williams M, Ahuja T, Raco V et al (2022) Real world prescribing practices of Apixaban or Rivaroxaban lead-in doses for the treatment of venous thromboembolism in hospitalized patients. J Thromb Thrombolysis 54(2):219\u2013229. https:\/\/doi.org\/10.1007\/s11239-022-02641-5","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"3181_CR11","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/jth.15358","volume":"19","author":"KA Martin","year":"2021","unstructured":"Martin KA, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S (2021) Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC subcommittee on control of anticoagulation. J Thromb Haemost 19(8):1874\u20131882. https:\/\/doi.org\/10.1111\/jth.15358","journal-title":"J Thromb Haemost"},{"issue":"23","key":"3181_CR12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123(23):2736\u20132747. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.009449","journal-title":"Circulation"},{"issue":"1","key":"3181_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1182\/hematology.2020002268","volume":"2020","author":"FN \u00c1inle","year":"2020","unstructured":"\u00c1inle FN, Kevane B (2020) Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)? Hematol Am Soc Hematol Educ Program 2020(1):201\u2013212. https:\/\/doi.org\/10.1182\/hematology.2020002268","journal-title":"Hematol Am Soc Hematol Educ Program"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03181-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03181-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03181-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:22:45Z","timestamp":1774426965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03181-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3181"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03181-4","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}